As of early September 2026, CDC data show 3,134 confirmed U.S. measles cases year-to-date—the highest annual total since 1991—driven by persistent outbreaks in Pennsylvania (over 550 cases), South Carolina, Utah, and several other states, with 95% outbreak-associated and 94% of patients unvaccinated or with unknown status. This surge exceeds 2025’s full-year count of 2,289 and stems from declining MMR coverage in under-vaccinated communities, enabling sustained local transmission of the highly contagious airborne virus. Trader sentiment for 2026 totals centers on weekly CDC surveillance updates and state reporting, which track case thresholds, hospitalization rates around 8%, and any shift toward endemic status, amid model projections of further spread before year-end.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · ОновленоВипадки кору в США в 2026 році?
Випадки кору в США в 2026 році?
$7,894,722 Обс.
$7,894,722 Обс.
Dec 31, 2026
↑3.5k
100%
↑4к
96%
↑4.5k
87%
↑4.75k
82%
↑5к
64%
↑7,5 тис.
15%
↑10 тис.
7%
↑12,5 тис.
2%
$7,894,722 Обс.
$7,894,722 Обс.
Dec 31, 2026
↑3.5k
$15,502 Обс.
100%
↑4к
$240,759 Обс.
96%
↑4.5k
$2,485 Обс.
87%
↑4.75k
$568 Обс.
82%
↑5к
$241,133 Обс.
64%
↑7,5 тис.
$193,280 Обс.
15%
↑10 тис.
$6,524,515 Обс.
7%
↑12,5 тис.
$356,524 Обс.
2%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, CDC data show 3,134 confirmed U.S. measles cases year-to-date—the highest annual total since 1991—driven by persistent outbreaks in Pennsylvania (over 550 cases), South Carolina, Utah, and several other states, with 95% outbreak-associated and 94% of patients unvaccinated or with unknown status. This surge exceeds 2025’s full-year count of 2,289 and stems from declining MMR coverage in under-vaccinated communities, enabling sustained local transmission of the highly contagious airborne virus. Trader sentiment for 2026 totals centers on weekly CDC surveillance updates and state reporting, which track case thresholds, hospitalization rates around 8%, and any shift toward endemic status, amid model projections of further spread before year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Ринок відкрито: Jun 30, 2026, 2:17 PM ET
Обсяг
$7,894,722Дата завершення
Jan 1, 2027Ринок відкрито
Jun 30, 2026, 2:17 PM ETВирішувач
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early September 2026, CDC data show 3,134 confirmed U.S. measles cases year-to-date—the highest annual total since 1991—driven by persistent outbreaks in Pennsylvania (over 550 cases), South Carolina, Utah, and several other states, with 95% outbreak-associated and 94% of patients unvaccinated or with unknown status. This surge exceeds 2025’s full-year count of 2,289 and stems from declining MMR coverage in under-vaccinated communities, enabling sustained local transmission of the highly contagious airborne virus. Trader sentiment for 2026 totals centers on weekly CDC surveillance updates and state reporting, which track case thresholds, hospitalization rates around 8%, and any shift toward endemic status, amid model projections of further spread before year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Обсяг
$7,894,722Дата завершення
Jan 1, 2027Ринок відкрито
Jun 30, 2026, 2:17 PM ETВирішувач
0x65070BE91...As of early September 2026, CDC data show 3,134 confirmed U.S. measles cases year-to-date—the highest annual total since 1991—driven by persistent outbreaks in Pennsylvania (over 550 cases), South Carolina, Utah, and several other states, with 95% outbreak-associated and 94% of patients unvaccinated or with unknown status. This surge exceeds 2025’s full-year count of 2,289 and stems from declining MMR coverage in under-vaccinated communities, enabling sustained local transmission of the highly contagious airborne virus. Trader sentiment for 2026 totals centers on weekly CDC surveillance updates and state reporting, which track case thresholds, hospitalization rates around 8%, and any shift toward endemic status, amid model projections of further spread before year-end.
Експериментальне резюме, згенероване ШІ з посиланням на дані Polymarket. Це не торгова порада і не впливає на вирішення цього ринку. · Оновлено
Обережно з зовнішніми посиланнями.
Обережно з зовнішніми посиланнями.
Часті запитання